Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies

by Serena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Published 2020-05-01

Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment

by Christine Lebrun-Frenay, Ilona Berestjuk, Mikael Cohen, Sophie Tartare-Deckert
Published 2020-07-01

LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer

by Jean Albrengues, Isabelle Bourget, Catherine Pons, Vincent Butet, Paul Hofman, Sophie Tartare-Deckert, Chloe C. Feral, Guerrino Meneguzzi, Cedric Gaggioli
Published 2014-06-01

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.

by Nina Fenouille, Mélanie Tichet, Maeva Dufies, Anaïs Pottier, Ariane Mogha, Julia K Soo, Stéphane Rocchi, Aude Mallavialle, Marie-Dominique Galibert, Amir Khammari, Jean-Philippe Lacour, Robert Ballotti, Marcel Deckert, Sophie Tartare-Deckert
Published 2012-01-01

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

by Caroline Imbert, Anne Montfort, Marine Fraisse, Elie Marcheteau, Julia Gilhodes, Elodie Martin, Florie Bertrand, Marlène Marcellin, Odile Burlet-Schiltz, Anne Gonzalez de Peredo, Virginie Garcia, Stéphane Carpentier, Sophie Tartare-Deckert, Pierre Brousset, Philippe Rochaix, Florent Puisset, Thomas Filleron, Nicolas Meyer, Laurence Lamant, Thierry Levade, Bruno Ségui, Nathalie Andrieu-Abadie, Céline Colacios
Published 2020-01-01